Low Uptake of Long-Acting Injectables in the First 2.5 Years Following Approval Among a Cohort of People Living With HIV
Open Forum Infect Dis
.
2024 May 16;11(5):ofae087.
doi: 10.1093/ofid/ofae087.
eCollection 2024 May.
Authors
Priyanka Manghani
1
,
Anne Monroe
1
,
Amanda Castel
1
,
Princy Kumar
2
,
Jennifer Phunmongkol
2
,
Rachel Denyer
3
4
,
Lauren O'Connor
1
Affiliations
1
Department of Epidemiology, Milken Institute School of Public Health, George Washington University, Washington, DC, USA.
2
Division of Infectious Diseases, Georgetown University School of Medicine, Washington, DC, USA.
3
Infectious Disease Division, Veterans Affairs Medical Center, Washington, DC, USA.
4
School of Medicine and Health Sciences, George Washington University, Washington, DC, USA.
PMID:
38756764
PMCID:
PMC11097117
DOI:
10.1093/ofid/ofae087
No abstract available
Grants and funding
R24 AI152598/AI/NIAID NIH HHS/United States
UM1 AI069503/AI/NIAID NIH HHS/United States